Trinity Biotech reported $25.91M in Cash and Equivalent for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Abbott ABT:US $ 7675M 2124M
Bayer BAYN:GR € 5785M 1221M
Bio Rad Laboratories BIO:US $ 802.32M 331.53M
Cytori Therapeutics CYTX:US $ 21.24M 2.84M
Edap Tms EDAP:US $ 46.5M 0.68M
Mesa Laboratories MLAB:US $ 51.71M 226.59M
Orasure Technologies OSUR:US $ 70.72M 46.04M
Siemens SIE:GR € 9495M 2704M
Sientra SIEN:US $ 38.88M 12.89M
Surmodics SRDX:US $ 24.71M 1.94M
Thermo Fisher Scientific TMO:US $ 2752M 1725M
Tosoh 4042:JP Y 161516M 16748M
Veracyte VCYT:US $ 163.62M 9.58M